Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression (2018)
- Authors:
- USP affiliated authors: LOTUFO, PAULO ANDRADE - FM ; GATTAZ, WAGNER FARID - FM ; BENSEÑOR, ISABELA JUDITH MARTINS - FM
- Unidade: FM
- DOI: 10.1016/j.pnpbp.2018.06.003
- Subjects: DEPRESSÃO; ANTIDEPRESSIVOS; INTERLEUCINAS; BIOMARCADORES
- Agências de fomento:
- CAPES / INCT program ""National Institute of Biomarkers in Psychiatry"" (INBioN)
- Beneficent Association Alzira Denise Hertzog da Silva
- CAPES/ Alexander von Humboldt fellowship
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Brain and Behavior (NARSAD) [2013/20493]
- FAPESP Young Investigator [2012/20911-5]
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
- Language: Inglês
- Imprenta:
- Source:
- Título: Progress in neuro-psychopharmacology & biological psychiatry
- ISSN: 0278-5846
- Volume/Número/Paginação/Ano: v. 86, p. 211-217, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BRUNONI, Andre R et al. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression. Progress in neuro-psychopharmacology & biological psychiatry, v. 86, p. 211-217, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2018.06.003. Acesso em: 24 jan. 2026. -
APA
Brunoni, A. R., Padberg, F., Vieira, E. L. M., Teixeira, A. L., Carvalho, A. F., Lotufo, P. A., et al. (2018). Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression. Progress in neuro-psychopharmacology & biological psychiatry, 86, 211-217. doi:10.1016/j.pnpbp.2018.06.003 -
NLM
Brunoni AR, Padberg F, Vieira ELM, Teixeira AL, Carvalho AF, Lotufo PA, Gattaz WF, Benseñor IJM. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression [Internet]. Progress in neuro-psychopharmacology & biological psychiatry. 2018 ; 86 211-217.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1016/j.pnpbp.2018.06.003 -
Vancouver
Brunoni AR, Padberg F, Vieira ELM, Teixeira AL, Carvalho AF, Lotufo PA, Gattaz WF, Benseñor IJM. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression [Internet]. Progress in neuro-psychopharmacology & biological psychiatry. 2018 ; 86 211-217.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1016/j.pnpbp.2018.06.003 - BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial
- Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial
- Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial
- Efficacy and safety of transcranial direct current stimulation as an add-on treatment for bipolar depression: a randomized clinical trial
- Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: a machine learning analysis of the ELECT-TDCS study
- Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis.
- Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial
- Comorbid association of obstructive sleep apnea (OSA) and thrombotic primary antiphospholipid syndrome (tPAPS): a more severe phenotype?
- HIV Infection Is Not Associated With Aortic Stiffness. Traditional Cardiovascular Risk Factors Are the Main Determinants-Cross-sectional Results of INI-ELSA-BRASIL
- Raça e mortalidade cerebrovascular no Brasil
Informações sobre o DOI: 10.1016/j.pnpbp.2018.06.003 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
